168. エーラス・ダンロス症候群 Ehlers-Danlos syndrome Clinical trials / Disease details

臨床試験数 : 13 / 薬物数 : 21 - (DrugBank : 11) / 標的遺伝子数 : 11 - 標的パスウェイ数 : 103

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02597361 (ClinicalTrials.gov)	January 2016	23/10/2015	Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)	Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome: a Double Blind, Randomized, Pla ...	Ehlers-Danlos Syndrome, Vascular Type	Drug: Irbesartan;Drug: Placebo	Assistance Publique - Hôpitaux de Paris	Ministry of Health, France	Completed	18 Years	70 Years	All	61	Phase 3	France
2	EUCTR2015-001065-76-FR (EUCTR)	28/09/2015	08/09/2015	N/A	N/A - ARCADE	MedDRA version: 18.0;Level: PT;Classification code 10014316;Term: Ehlers-Danlos syndrome;System Org ...	Trade Name: IRBESARTAN Product Name: IRBESARTAN INN or Proposed INN: irbesartan	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)	NULL	Not Recruiting			Female: yes Male: yes	169	Phase 3	France

First Previous1Next Last